STOCK WARRANTS (Details Narrative) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Jun. 02, 2023 |
Jun. 01, 2023 |
Mar. 03, 2023 |
|
| Stock warrants granted | $ 32,723 | ||||
| Stock warrants granted and vested | 1,564,350 | 1,607,901 | |||
| Warrant [Member] | |||||
| Compensation expense | 1,564,350 | $ 1,589,191 | |||
| Future compensation cost | 1,190,594 | ||||
| Outstanding and exercisable warrants | $ 21,000 | ||||
| Estimated fair value per share | $ 0.06 | ||||
| Chief Executive Officer [Member] | |||||
| Number of securities called by warrants or rights | 150,000 | 114,286 | |||
| Notes Payable | $ 800,000 | ||||
| Consultant [Member] | |||||
| Number of securities called by warrants or rights | 150,000 | ||||
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments granted value No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments vested value. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options exercisable weighted average average exercise price. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements. No definition available.
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|